Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin

dc.contributor.authorEubank, Taryn A.
dc.contributor.authorHu, Chenlin
dc.contributor.authorGonzales-Luna, Anne J.
dc.contributor.authorGarey, Kevin W.
dc.description.abstractVancomycin is not appreciably passaged via the colonic membrane to the gastrointestinal (GI) tract in persons with an intact gut epithelium due to its large chemical structure. However; hospitalized patients with diarrhea often have a disrupted GI tract. The aim of this study was to determine the frequency of detectable vancomycin concentrations in the stool of patients with antibiotic-associated diarrhea receiving IV vancomycin. This was a multicenter cohort study of hospitalized patients with stool samples collected for <i>Clostridioides difficile</i> testing. Leftover stool samples were collected from patients who had received at least 3 days of IV vancomycin. Fecal vancomycin was quantified by high-performance liquid chromatography. The study cohort included 33 unique patients, majority female (54.5%) aged 60 years (range 23&ndash;84). Eighteen of thirty-three patients (54.5%) tested positive for <i>C. difficile</i> toxins. The average duration of systemic vancomycin administration prior to stool collection was 3.5 (range 2&ndash;15) days. Three of 33 (9%) stool samples had a detectable vancomycin concentration (range 1.2&ndash;13.2 mcg/mL). These concentrations may promote the development of vancomycin-resistant <i>Enterococcus</i> or van mutations in <i>C. difficile</i>, leading to vancomycin resistance. Further studies on implications are warranted.
dc.identifierdoi: 10.3390/pharma2040024
dc.identifier.citationPharmacoepidemiology 2 (4): 283-288 (2023)
dc.titleDetectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin


Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
237.97 KB
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
1.67 KB
Item-specific license agreed upon to submission